<DOC>
	<DOC>NCT02184039</DOC>
	<brief_summary>Study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases.</brief_summary>
	<brief_title>Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<criteria>Hypersensitivity to meloxicam or to other NSAIDS History of asthma, angioedema or urticaria secondary to NSAIDS Pregnancy or lactation Recent or current history of peptic ulcer disease, severe renal failure, severe hepatic failure Age below of 12 years.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>